What we do
Corporate Governance Advisory Services
ESG Advisory Services
M&A and Information Agent Services
Capital Market Intelligence Services
Proxy Contests, Hostile takeovers, Shareholder Activism and Special Situations
Proxy Solicitation and Shareholder Meeting Services
Retail Services and Additional Capabilities
Board of Director Services
Debt Services
Services for Registered Funds - Mutual Funds, Exchange Traded Funds (ETFs) and Closed-End Funds - Di Costa Partners
Client Portal

Recent Mergers and Acquisitions

Celgene Acquisition by Bristol-Myers Squibb

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here

Topics

Celgene Acquisition by Bristol-Myers Squibb

Topics

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here

© 2016 - 2021 Morrow Sodali